|
1
|
Du J, Ma M, Zhao Q, Fang L, Chang J, Wang
Y, Fei R and Song X: Mitochondrial bioenergetic deficits in the
hippocampi of rats with chronic ischemia-induced vascular dementia.
Neuroscience. 231:345–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akinyemi R, Mukaetova-Ladinska E, Attems
J, Ihara M and Kalaria RN: Vascular risk factors and
neurodegeneration in ageing related dementias: Alzheimer's disease
and vascular dementia. Curr Alzheimer Res. 10:642–653. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benisty S: Current concepts in vascular
dementia. Geriatr Psychol Neuropsychiatr Vieil. 11:171–180.
2013.(In French). PubMed/NCBI
|
|
4
|
Grinberg LT, Nitrini R, Suemoto CK, Lucena
Ferretti-Rebustini RE, Leite RE, Farfel JM, Santos E, Andrade MP,
Alho AT, Lima Mdo C, et al: Prevalence of dementia subtypes in a
developing country: A clinicopathological study. Clinics (Sao
Paulo). 68:1140–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qi Q, Xu J, Lv P, Dong Y, Liu Z, Hu M,
Xiao Y, Jia Y, Jin W, Fan M, et al: DL-3-n-butylphthalide
alleviates vascular cognitive impairment induced by chronic
cerebral hypoperfusion by activating the Akt/Nrf2 signaling pathway
in the hippocampus of rats. Neurosci Lett. 672:59–64. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han QY, Zhang H, Zhang X, He DS, Wang SW,
Cao X, Dai YT, Xu Y and Han LJ: dl-3-n-butylphthalide preserves
white matter integrity and alleviates cognitive impairment in mice
with chronic cerebral hypoperfusion. CNS Neurosci Ther.
25:1042–1053. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
North BJ and Verdin E: Sirtuins:
Sir2-related NAD-dependent protein deacetylases. Genome Biol.
5:2242004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seo JS, Moon MH, Jeong JK, Seol JW, Lee
YJ, Park BH and Park SY: SIRT1, a histone deacetylase, regulates
prion protein-induced neuronal cell death. Neurobiol Aging.
33:1110–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zu G, Ji A, Zhou T and Che N:
Clinicopathological significance of SIRT1 expression in colorectal
cancer: A systematic review and meta analysis. Int J Surg.
26:32–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Liang Y and Vanhoutte PM: SIRT1
and AMPK in regulating mammalian senescence: A critical review and
a working model. FEBS Lett. 585:986–994. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Duan W, Li Y, Yan J, Yi W, Liang
Z, Wang N, Yi D and Jin Z: New role of silent information regulator
1 in cerebral ischemia. Neurobiol Aging. 34:2879–2888. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xia Y, Wang CZ, Liu J, Anastasio NC and
Johnson KM: Brain-derived neurotrophic factor prevents
phencyclidine-induced apoptosis in developing brain by parallel
activation of both the ERK and PI-3K/Akt pathways.
Neuropharmacology. 58:330–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castillo DV and Escobar ML: A role for
MAPK and PI-3K signaling pathways in brain-derived neurotrophic
factor modification of conditioned taste aversion retention. Behav
Brain Res. 217:248–252. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pandey SC, Zhang H, Roy A and Misra K:
Central and medial amygdaloid brain-derived neurotrophic factor
signaling plays a critical role in alcohol-drinking and
anxiety-like behaviors. J Neurosci. 26:8320–8331. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kramár EA, Chen LY, Lauterborn JC, Simmons
DA, Gall CM and Lynch G: BDNF upregulation rescues synaptic
plasticity in middle-aged ovariectomized rats. Neurobiol Aging.
33:708–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vetrovoĭ OV, Rybnikova TS and Samoĭlov MO:
Effect of hypoxic postconditioning on the expression of
antiapoptotic protein Bcl-2 and neurotrophin BDNF in CA1
hippocampal field of rats surviving severe hypoxia. Morfologiia.
145:16–20. 2014.(In Russian). PubMed/NCBI
|
|
17
|
Zhang T, Yan W, Li Q, Fu J, Liu K, Jia W,
Sun X and Liu X: 3-n-Butylphthalide (NBP) attenuated neuronal
autophagy and amyloid-β expression in diabetic mice subjected to
brain ischemia. Neurol Res. 33:396–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peng Y, Xu SF, Wang L, Feng YP and Wang
XL: Effects of chiral NBP on cerebral infarct volume due to
transient focal cerebral ischemia. Zhongguo Xinyao Zazhi.
14:420–423. 2005.
|
|
19
|
Dong GX and Feng YP: Effects of
3-N-butylphthalide on cortical calcineurin and calpain activities
in focal cerebral ischemia rats. Yao Xue Xue Bao. 35:790–792.
2000.(In Chinese). PubMed/NCBI
|
|
20
|
Liu CL, Liao SJ, Zeng JS, Lin JW, Li CX,
Xie LC, Shi XG and Huang RX: Dl-3n-Butylphthalide prevents stroke
via improvement of cerebral microvessels in RHRSP. J Neurol Sci.
260:106–113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng Y, Hu Y, Xu S, Feng N, Wang L and
Wang XL: L-3-n-butylphthalide regulates amyloid precursor protein
processing by PKC and MAPK pathways in SK-N-SH cells
over-expressing wild type human APP695. Neurosci Lett. 487:211–216.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng X, Peng Y, Liu M and Cui L:
DL-3-n-butylphthalide extends survival by attenuating glial
activation in a mouse model of amyotrophic lateral sclerosis.
Neuropharmacology. 62:1004–1010. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng Y, Xu S, Chen G, Wang L, Feng Y and
Wang X: l-3-n-Butylphthalide improves cognitive impairment induced
by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther.
321:902–910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghanbarabadi M, Iranshahi M, Amoueian S,
Mehri S, Motamedshariaty VS and Mohajeri SA: Neuroprotective and
memory enhancing effects of auraptene in a rat model of vascular
dementia: Experimental study and histopathological evaluation.
Neurosci Lett. 623:13–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee CH, Park JH, Ahn JH and Won MH:
Effects of melatonin on cognitive impairment and hippocampal
neuronal damage in a rat model of chronic cerebral hypoperfusion.
Exp Ther Med. 11:2240–2246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deacon RM and Rawlins JN: T-maze
alternation in the rodent. Nat Protoc. 1:7–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vorhees CV and Williams MT: Morris water
maze: Procedures for assessing spatial and related forms of
learning and memory. Nat Protoc. 1:848–858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bowler JV: The concept of vascular
cognitive impairment. J Neurol Sci 203-204. 11–15. 2002. View Article : Google Scholar
|
|
29
|
Bowler JV: Modern concept of vascular
cognitive impairment. Br Med Bull. 83:291–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gorelick PB, Scuteri A, Black SE, Decarli
C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL,
Nyenhuis D, et al: Vascular contributions to cognitive impairment
and dementia: A statement for healthcare professionals from the
American heart association/American stroke association. Stroke.
42:2672–2713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Román GC, Sachdev P, Royall DR, Bullock
RA, Orgogozo JM, López-Pousa S, Arizaga R and Wallin A: Vascular
cognitive disorder: A new diagnostic category updating vascular
cognitive impairment and vascular dementia. Neurol Sci. 226:81–87.
2004. View Article : Google Scholar
|
|
32
|
O'Brien JT: Vascular cognitive impairment.
Am J Geriatr Psychiatry. 14:724–733. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jia J, Wei C, Liang J, Zhou A, Zuo X, Song
H, Wu L, Chen X, Chen S, Zhang J, et al: The effects of
DL-3-n-butylphthalide in patients with vascular cognitive
impairment without dementia caused by subcortical ischemic small
vessel disease: A multicentre, randomized, double-blind,
placebo-controlled trial. Alzheimers Dement. 12:89–99. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen N, Zhou Z, Li J, Li BC, Feng JH, He
D, Luo Y, Zheng X, Luo J and Zhang J: 3-n-butylphthalide exerts
neuroprotective effects by enhancing anti-oxidation and attenuating
mitochondrial dysfunction in an in vitro model of ischemic stroke.
Drug Des Devel Ther. 12:4261–4271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu J, Huai Y, Meng N, Dong Y, Liu Z, Qi Q,
Hu M, Fan M, Jin W and Lv P: L-3-n-Butylphthalide activates
Akt/mTOR signaling, inhibits neuronal apoptosis and autophagy and
improves cognitive impairment in mice with repeated cerebral
ischemia-reperfusion injury. Neurochem Res. 42:2968–2981. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Niu XL, Jiang X, Xu GD, Zhang GM, Tang ZP,
Yin N, Li XQ, Yang YY and Lv PY: DL-3-n-butylphthalide alleviates
vascular cognitive impairment by regulating endoplasmic reticulum
stress and the Shh/Ptch1 signaling-pathway in rats. J Cell Physiol.
234:12604–12614. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xing M, Sun Q, Wang Y, Cheng Y and Zhang
N: Hydroxysafflor yellow A increases BDNF and NMDARs in the
hippocampus in a vascular dementia rat model. Brain Res.
1642:419–425. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ogawa T, Wakai C, Saito T, Murayama A,
Mimura Y, Youfu S, Nakamachi T, Kuwagata M, Satoh K and Shioda S:
Distribution of the longevity gene product, SIRT1, in developing
mouse organs. Congenit Anom (Kyoto). 51:70–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Michishita E, Park JY, Burneskis JM,
Barrett JC and Horikawa I: Evolutionarily conserved and
nonconserved cellular localizations and functions of human SIRT
proteins. Mol Biol Cell. 16:4623–4635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shan T, Wang Y, Wu T, Liu C, Guo J, Zhang
Y, Liu J and Xu Z: Porcine sirtuin 1 gene clone, expression
pattern, and regulation by resveratrol. J Anim Sci. 87:895–904.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Michán S, Li Y, Chou MH, Parrella E, Ge H,
Long JM, Allard JS, Lewis K, Miller M, Xu W, et al: SIRT1 is
essential for normal cognitive function and synaptic plasticity. J
Neurosci. 30:9695–9707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen YY, Zhang L, Shi DL, Song XH, Shen
YL, Zheng MZ and Wang LL: Resveratrol attenuates subacute systemic
inflammation-induced spatial memory impairment via inhibition of
astrocyte activation and enhancement of synaptophysin expression in
the hippocampus. Ann Clin Lab Sci. 47:17–24. 2017.PubMed/NCBI
|
|
43
|
Wang R, Zhang Y, Li J and Zhang C:
Resveratrol ameliorates spatial learning memory impairment induced
by Aβ1-42 in rats. Neuroscience. 344:39–47. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li XH, Chen C, Tu Y, Sun HT, Zhao ML,
Cheng SX, Qu Y and Zhang S: Sirt1 promotes axonogenesis by
deacetylation of Akt and inactivation of GSK3. Mol Neurobiol.
48:490–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li XH, Lv BL, Xie JZ, Liu J, Zhou XW and
Wang JZ: AGEs induce Alzheimer-like tau pathology and memory
deficit via RAGE-mediated GSK-3 activation. Neurobiol Aging.
33:1400–1410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Watzlawick R, Howells DW and Schwab JM:
Neuroprotection aftr traumatic brain injury. JAMA Neurol.
73:149–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kaplan GB, Vasterling JJ and Vedak PC:
Brain-derived neurotrophic factor in traumatic brain injury,
post-traumatic stress disorder, and their comorbid conditions: Role
in pathogenesis and treatment. Behav Pharmacol. 21:427–437. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xiang J, Pan J, Chen F, Zheng L, Chen Y,
Zhang S and Feng W: L-3-n-butylphthalide improves cognitive
impairment of APP/PS1 mice by BDNF/TrkB/PI3K/AKT pathway. Int J
Clin Exp Med. 7:1706–1713. 2014.PubMed/NCBI
|
|
49
|
Koppula S, Kumar H, More SV, Kim BW, Kim
IS and Choi DK: Recent advances on the neuroprotective potential of
antioxidants in experimental models of Parkinson's disease. Int J
Mol Sci. 13:10608–10629. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wu Y, Huang Q, Liu X and Wei X:
Dl-3-n-butylphthalide is effective for demyelination: A
case-combined study. Clin Neurol Neurosurg. 137:83–88. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang C, Zhao S, Zang Y, Gu F, Mao S, Feng
S, Hu L and Zhang C: The efficacy and safety of
Dl-3n-butylphthalide on progressive cerebral infarction: A
randomized controlled STROBE study. Medicine (Baltimore).
96:e72572017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang X, Wang L, Sheng X, Huang Z, Li T,
Zhang M, Xu J, Ji H, Yin J and Zhang Y: Design, synthesis and
biological evaluation of hydrogen sulfide releasing derivatives of
3-n-butylphthalide as potential antiplatelet and antithrombotic
agents. Org Biomol Chem. 12:5995–6004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zeng Y and Yang K: SIRT1uin 1 participates
in the process of age-related retinal degeneration. Biochem Biophys
Res Commun. 468:167–172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jiang M, Wang J, Fu J, Du L, Jeong H, West
T, Xiang L, Peng Q, Hou Z, Cai H, et al: Neuroprotective role of
Sirt1 in mammalian models of Huntington's disease through
activation of multiple Sirt1 targets. Nat Med. 18:153–158. 2011.
View Article : Google Scholar : PubMed/NCBI
|
